Språk:
Valuta:
0 VARER - $0.00 Bonus: 2
Generic Glyxambi (Linagliptin/empagliflozin)
Glyxambi
Glyxambi is a prescription medication used to control blood sugar in adults with type 2 diabetes. It combines empagliflozin and linagliptin to help regulate glucose levels and support overall glycemic management.
Velg Doser: 25/5mg
25/5mg
30piller
Glyxambi $215.99
$179.99
$6.00 per pille
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $0.00
25/5mg
60piller
Glyxambi $424.79
$353.99
$5.90 per pille
+ Free trackable courier service
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $6.00
25/5mg
90piller
Glyxambi $621.59
$517.99
$5.76 per pille
+ Free trackable courier service
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $21.60
Package Example
Din bestilling vil bli pakket trygt og sikkert, og normalt innen 24 timer. Dette er nøyaktig hvordan pakken vil se ut (bilder av en ekte leveranse). Den har en størrelse og en utseende som et vanlig privat brev (9.4x4.3x0.3 tommer eller 24x11x0.7cm) og det avslører ikke innholdet
Leveringstid
Levering 14-21 dager 10$ Sporing # tilgjengelig i 4 dager
Gratis standard luftpost service for alle bestillinger med sum på $200 og over
Levering 5-9 dager 30$ Sporing # tilgjengelig i 2 dager
Gratis sporbar tjeneste for alle bestillinger med sum på $300 og over
Frakt over hele verden Konfidensialitet og anonymitet garanti
Trygt og sikkert Discreet looking packages
Afsendelse af ordrer indenfor 24 timer 100% levering success
Attester Produktbeskrivelse
Det er ingen tilbakemeldinger for dette produktet for øyeblikket, men du kan være den første til å legge til en ellers kan du lese mer på tilbakemeldingssiden om relaterte produkter .

Legg Til Anmeldelse

Common Use
Glyxambi is prescribed for adults with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise alone. It helps lower blood glucose by promoting glucose excretion through urine and enhancing the body’s natural insulin response. Maintaining proper blood sugar levels reduces the risk of diabetes-related complications.

Dosage and Direction
The recommended dose is one tablet taken orally once daily, with or without food, or as directed by a healthcare provider. Swallow the tablet whole with water and take it at the same time each day. Do not change the dose without consulting your doctor.

Precautions
Before using Glyxambi, inform your doctor if you have kidney or liver disease, low blood pressure, or a history of urinary tract infections. Monitor blood sugar regularly and stay hydrated to avoid dehydration. Avoid driving or operating machinery if you experience dizziness or low blood sugar.

Contraindications
Glyxambi should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe kidney impairment, or known hypersensitivity to empagliflozin, linagliptin, or any component of the tablet.

Possible Side Effects
Common side effects include urinary tract infections, hypoglycemia (especially when combined with insulin), headache, and nasopharyngitis. Rare but serious effects may include dehydration, kidney problems, or ketoacidosis. Seek medical attention if severe symptoms occur.

Drug Interaction
Glyxambi may interact with insulin, sulfonylureas, diuretics, or other medications affecting kidney function or blood sugar. These interactions can increase the risk of hypoglycemia or dehydration. Inform your healthcare provider about all medications and supplements you are taking.

Missed Dose
If a dose is missed, take it as soon as you remember. If it is close to the time of the next dose, skip the missed dose. Do not take a double dose to make up for a missed one.

Overdose
Overdose may cause severe hypoglycemia, dehydration, or kidney problems. Seek immediate medical attention if an overdose is suspected.

Storage
Store Glyxambi tablets at room temperature, away from heat, moisture, and direct sunlight. Keep out of reach of children. Do not use after the expiration date.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Attester
Johnny, 34
Til tross for dette var min første on-line bestilling, og jeg nølte lenge for å betale med kredittkort gjennom nettstedet og få falske produkter i retur, jeg tok en risiko og fikk det jeg ønsket. Det sier seg selv at produktet var ekte og kom når jeg ...
Peter, Wien
Jeg har prøvd Viagra og Cialis før og må si at Levitra forårsaker mindre bivirkninger skjønt. Jeg hadde fryktelig hodepine med Viagra som gjorde sex umulig noen ganger. Med Levitra glemte jeg om det. Jeg vil anbefale det til alle som har lignende problemer, ...
Malcolm, 63, Canada
"Min Levitra kom i går. Det er en magisk! Jeg hadde en uforglemmelig kveld. Jeg er heldig at jeg bestilte en stor pakke av det. Det vil vare lenge. Jeg kan ikke uttrykke mine følelser, jeg er overveldet. Det virker i meg som ingen annen kur for ereksjon. ...
Les mer...

Forsendelsesmåte

Sikker Betalingsprosess
Nyheter
BBC investigation finds 50,000 people waited over 24 hours in A&E corridor care
Known as "corridor care", patients are lining up on trolleys or sitting on chairs due to a lack of beds.
'Doctors said my excruciating period pain was anxiety'
Women with endometriosis say doctors failed to listen to them or take their pain seriously.
Taking collagen keeps skin more elastic but won't stop wrinkles, say scientists
The new review brings together the strongest evidence to date on collagen supplementation, say experts.
Jersey passes assisted dying law - but what stage has proposal reached in UK's parliaments?
Bills to let terminally ill people end their life are being considered at Westminster and in Scotland.